Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-02-21
1995-10-24
Wityshyn, Michael G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 2, 514 21, 530351, 424 851, C07K 14495, A61K 3818
Patent
active
054610338
ABSTRACT:
The expression of Class II antigen expression by intestinal epithelial cells is modulated by administering to a mammal in need thereof an effective amount of TGF-.beta.2.
REFERENCES:
patent: 4440860 (1984-04-01), Klagsbrun
Skulme "The Etiology, Pathenogenesis & Early Diagnosis of Cancer & Precancerous Diseases of The Stomach" pp. 148-149 1959.
Chemical Abstracts, vol. 107, No. 9, Aug. 31, 1987, No. 76199v.
Pediatric Research, El-Youssel, et al., vol. 25, No. 4, pp. 269A, 1989.
Immunology, Hughes, et al, "Expression of MHC class II (Ia) Antigen by the Neonatal Enterocyte: The effect of treatment with interferon-gamma." vol. 72, pp. 491-496, 1991.
European Journal of Biochemistry, Cox, D. T., et al., vol. 197, No. 2, pp. 353-358, Apr. 1991.
Journal of Protein Chemistry, Jin, Y., et al, vol. 10, No. 5, pp. 565-575, 1991.
Benacerraf, B., Role of MHC Gene Products in Immune Regulation, Science, 212, 1229 (1981).
Czarniecki, C. W., et al., Transforming Growth Factor-.beta..sub.1 Modulates The Expression of Class IV Histocompatibility Antigens On Human Cells, J. Immunol., 140, 4217-4223 (1988).
Huggett, A. C. et al., Altered Responsiveness of Rat Liver Epithelial Cells To Transforming Growth Factor .beta..sub.1 Following Their Transformation With V-raf, Cancer Res., 50, 7768-7775 (1990).
Kehrl, J. H. et al., Transforming Growth Factor .beta. Is An Important Immunomodulatory Protein for Human B Lymphocytes, J. Immunol., 137, 3855-3860 (1986).
Kehrl, J. H. et al., Production Of Transforming Growth Factor .beta. By Humman T Lymphocytes And Its Potential Role in The Regulation of T Cell Growth, J. Exp. Med., 163, 1037-Poso (1986).
Lebman D. A., et al., Mechanism For Transforming Growth Factor .beta. and IL-2 Enhancement of IgA Expression In Lipopolysaccharide-Stimulated B Cell Cultures, J. Immunol., 144, 952-959 (1990).
Mayer, L., et al., Evidence for Function Ia Molecules on Gut Epithelial Cells in Man, J. Exp. Med. 166, 1471-1483 (1987).
Mayer, L., et al. Expression of Class II Moleucles On Intestinal Epithelial Cells In Humans, Gastroenterology, 100, 3-12 (1991).
Quaroni, A. et al., Epithelial Cell Cultures From Rat Small Intestine, J. Cell, Biology, 80, 248 (1979).
Roberts, A. B., et al., The Transforming Growth Factor-.beta.s, Peptide Growth Factors and Their Receptors, vol. 1, 419-472, eds. Sporn M. B., et al., Springer (1990).
Ristow, H. J., BSC-1 Growth Inhibitor/Type .beta. Transforming Growth Factor Is a Strong Inhibitor of Thymocyte Proliferation Proc Natl. Acd Sci USA, 83, 5531-5533, (1986).
Schlusener, H. J., Transforming Growth Factors Type .beta..sub.1 and .beta..sub.2 Suppress Rat Astrocyte Autoantigen Presentation and Antagonize Hyperinduction of Class II Major Histocompatibility Complex Antigen Expression By Interferon-.gamma. and Tumor Necrosis Factor .alpha., J. Neuroimmunol., 27, 41-47, (1990).
Smith, P. K., Measurement of Protein Using Bicinchoninic Acid, et al., Annl. Biochem, 150, 76-85, (1985).
Snook, J. A., et al., Serum and Tissue Autoantibodies To Colonic Epithelium In Ulcerative Colitis, Gut, 32, 163-166, (1991).
Stoeck, M., et al. Comparison of the Immunosuppressive Properties of Milk Growth Factor and Transforming Growth Factors .beta.1 and .beta.2, J. Immunol., 143, 3258-3265 (1989).
Stoeck, M. et al., Transforming Growth Factors .beta.1 and .beta.2 as Well As Milk Growth Factor Decrease Anti-DC3-Induced Proliferation of Human Lymphocytes Without Inhibiting the Anti-CD3-Mediated Increase of [Ca.sup.2+ ].sub.i and The Activation of Protein Kinase C, FEBS Lett., 249, 289 292 (1989).
West, D. W., The Origin, Transport and Function of Hormones and Growth Factors In Milk, Exp. Clin. Endocrinol, 8, 145-146 (1989).
Zuber P., et al; Transforming Growth Factor-.beta.2 Down-Regulates HLA-DR Antigen Expression on Human Malignant Glioma Cells, Eur. J. Immunol 18, 1623-1626 (1988).
Zweibaum, A., et al., Enterocytic Differentiation of A Subpopulation of the Human Colon Tumor Cell Line HT-29 Selected For Growth In Sugar-Free Medium and its Inhibition By Glucose, J. Cell Physiol; 122, 21 (1985).
Challenges In IBD Research: Agenda for The 1990's, National Foundation for Ileitis and Colitis, Feb. 21, 1990, Washington, D.C.
Donnet Anne
Huggett Anthony C.
Schiffrin Eduardo
Degen Nancy J.
Nestec S.A.
Wityshyn Michael G.
LandOfFree
Modulation of class II antigen expression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modulation of class II antigen expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulation of class II antigen expression will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1886663